Rania Jalal has more than 20 years of experience in Pharmaceutical Development, Chemistry, Manufacturing, and Controls (CMC). Rania has worked at small, mid, and large pharmaceutical and biotech companies across a variety of dosage forms, from early proof-of-concept (Phase 1) to commercial readiness.
Prior to joining Halloran, Rania was self-employed at RJ Pharma Consulting, LLC. Rania focused on providing technical and strategic CMC expertise in drug product development and manufacturing processes, as well as CMC strategic planning of regulatory submissions. This included performing gap analysis for the CMC package, pre-IND and End of Phase (EOP2) Agency meeting requests and briefing document preparation, as well as preparation of CMC modules for a variety of regulatory submissions (IND, NDA, 505 b(2), ANDA, BLA, CTA, and IMPD).
Rania holds a PhD. in Pharmaceutics from the University of Manchester, a B.S. in Pharmacy from Applied Science University, and a Project Management Certificate from the University of St. Thomas.